Viewing Study NCT01216657


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2025-12-25 @ 4:36 PM
Study NCT ID: NCT01216657
Status: TERMINATED
Last Update Posted: 2013-06-04
First Post: 2010-04-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma
Sponsor: Krankenhaus Nordwest
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module